Karen Astrid Boldingh Debernard

Author information from the last article

Karen Astrid Boldingh Debernard er cand.pharm., ph.d. og spesialrådgiver ved RELIS Sør-Øst, Avdeling for farmakologi og ved Spesialsykehuset for epilepsi, Oslo universitetssykehus.

Articles by Karen Astrid Boldingh Debernard

Ketamine for depression – a critical perspective

Karen Astrid Boldingh Debernard,
Tone Westergren,
Henning Gustav Økland,
Anne Katrine Eek

03.03.2026: Ketamine is described as a promising agent with rapid antidepressant effects. However, the evidence is more limited than many believe and has significant methodological weaknesses. For several years, ketamine has been given to patients with depression at private clinics and some hospital departments...

Quetiapine is not a sleeping pill

Karen Astrid Boldingh Debernard,
Joachim Frost,
Pål-Didrik Hoff Roland

16.09.2019: Use of the antipsychotic drug quetiapine to treat sleep disorders has become widespread, also in Norway. Its efficacy is poorly documented, and even low doses may have substantial side effects. There is thus reason to warn against prescribing quetiapine for sleep. Quetiapine is a second-generation...